5 research outputs found
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: an Open Label, Non-Randomized, Controlled Study
<p><b>Article full text</b></p><p><br></p><p>The full text of this article can
be found here <a href="https://link.springer.com/article/10.1007/s13300-018-0373-9">https://link.springer.com/article/10.1007/s13300-018-0373-9</a></p><p><br></p><p><b>Provide enhanced content for this
article</b></p><p><br></p><p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact [email protected].</p><p> </p><p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p><p><br></p><p>Other enhanced features include,
but are not limited to:</p><p><br></p><p>• Slide decks</p><p>• Videos and animations</p><p>• Audio abstracts</p><p>
</p><p>• Audio slides</p><ul>
</ul>
<p> </p
Cumulative change from baseline in (A) body mass and fat mass from dual-energy x-ray absorptiometry, (B) fasting lipoproteins, (C) insulin resistance determined from homeostatic model assessment (HOMA), and (D) blood pressure in 16 subjects who switched to a very low carbohydrate diet and then incrementally increased carbohydrate every 3 wk over six sequential phases (C1→C2→C3→C4→C5→C6).
<p>BL  =  baseline, FL  =  free-living low-carbohydrate diet). Significant differences from Baseline vs C1 were determined by dependent t-test and indicated by an asterisk. Differences from C1 to C6 were determined by repeated measures ANOVA and Fisher's LSD post hoc. Different letters at a time point indicate statistical significance.</p
Daily nutrient intakes at baseline (habitual diet) and during each dietary phase<sup>1</sup>.
<p><i><sup>1</sup>Values are mean ± SD.</i></p><p><i><sup>2</sup>Determined from 3-day diet records.</i></p><p>Daily nutrient intakes at baseline (habitual diet) and during each dietary phase<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113605#nt105" target="_blank">1</a></sup>.</p
Baseline subject characteristics<sup>1</sup>.
<p><i><sup>1</sup>Values are mean ± SD (range).</i></p><p><i><sup>2</sup>Determined by dual-energy X-ray absorptiometry.</i></p><p><i><sup>3</sup>HOMA  =  homeostatic model assessment  =  [fasting glucose (mmol/L) x insulin (mU/L)]/22.5.</i></p><p><i>*5 subjects were using anti-hypertensive medications.</i></p><p>Baseline subject characteristics<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113605#nt101" target="_blank">1</a></sup>.</p
Plasma fatty acid responses<sup>1</sup>.
<p><i><sup>1</sup>Values are mean ± SD from 16. SFA  =  total saturated fatty acids; MUFA  =  total monounsaturated fatty acids.</i></p><p><i><sup>2</sup>C1  =  lowest carbohydrate diet and C6  =  highest carbohydrate intake.</i></p><p><i><sup>3</sup>3wk run-in diet phase before entering feeding portion of study.</i></p><p><i><sup>4</sup>Dependent t-test (Baseline vs C1).</i></p><p>Plasma fatty acid responses<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113605#nt107" target="_blank">1</a></sup>.</p